Approval Summary for Erlotinib for Treatment of Patients with Locally Advanced or Metastatic Non–Small Cell Lung Cancer after Failure of at Least One Prior Chemotherapy Regimen

John R. Johnson; Martin Cohen; Rajeshwari Sridhara; Yeh-Fong Chen; Gene M. Williams; John Duan; Jogarao Gobburu; Brian Booth; Kimberly Benson; John Leighton; Li Shan Hsieh; Nallalerumal Chidambaram; Paul Zimmerman; Richard Pazdur

doi:10.1158/1078-0432.ccr-05-0790

Approval Summary for Erlotinib for Treatment of Patients with Locally Advanced or Metastatic Non–Small Cell Lung Cancer after Failure of at Least One Prior Chemotherapy Regimen

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-05-0790 ◽

2005 ◽

Vol 11 (18) ◽

pp. 6414-6421 ◽

Cited By ~ 148

Author(s):

John R. Johnson ◽

Martin Cohen ◽

Rajeshwari Sridhara ◽

Yeh-Fong Chen ◽

Gene M. Williams ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Chemotherapy Regimen ◽

Locally Advanced ◽

Small Cell ◽

Small Cell Lung ◽

Prior Chemotherapy ◽

Prior Chemotherapy Regimen

Download Full-text

Activity of ZD0473 in small-cell lung cancer: an update in patients relapsing after one prior chemotherapy regimen

European Journal of Cancer ◽

10.1016/s0959-8049(01)80711-5 ◽

2001 ◽

Vol 37 ◽

pp. S62 ◽

Cited By ~ 3

Author(s):

J. Schiller ◽

P. Bonomi ◽

M. Modiano ◽

P. Cornett ◽

M. Koehler

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Chemotherapy Regimen ◽

Small Cell ◽

Small Cell Lung ◽

Prior Chemotherapy ◽

Prior Chemotherapy Regimen

Download Full-text

120P Optimal chemotherapy regimen for concurrent chemo-radiotherapy of locally advanced unresectable stage III non-small cell lung cancer (NCSLC)

Journal of Thoracic Oncology ◽

10.1016/s1556-0864(18)30394-0 ◽

2018 ◽

Vol 13 (4) ◽

pp. S66-S67

Author(s):

N. Jokhadze ◽

I. Kiladze ◽

L. Katselashvili ◽

M. Kacharava ◽

N. Jankarashvili ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Chemotherapy Regimen ◽

Locally Advanced ◽

Small Cell ◽

Stage Iii ◽

Small Cell Lung ◽

Unresectable Stage

Download Full-text

Final Overall Results of a Study with a Novel Triplet Induction Chemotherapy Regimen (PACCAGE) Followed by Consolidation Radiotherapy in Locally Advanced Inoperable Non-small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology ◽

10.1097/jto.0b013e3181a4ec14 ◽

2009 ◽

Vol 4 (6) ◽

pp. 728-735 ◽

Cited By ~ 8

Author(s):

Denis Schallier ◽

Samuel Bral ◽

Bart Ilsen ◽

Bart Neyns ◽

Christel Fontaine ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Induction Chemotherapy ◽

Cell Lung Cancer ◽

Chemotherapy Regimen ◽

Locally Advanced ◽

Small Cell ◽

Small Cell Lung ◽

Consolidation Radiotherapy

Download Full-text

PCN148 - COST-EFFECTIVENESS ANALYSIS OF ATEZOLIZUMAB COMPARED TO TREATMENT OPTIONS FOR ADULT PATIENTS WITH LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC) AFTER PRIOR CHEMOTHERAPY - UPDATED RESULTS

Value in Health ◽

10.1016/j.jval.2018.09.231 ◽

2018 ◽

Vol 21 ◽

pp. S39-S40

Author(s):

N. Kourkoulas ◽

K. Athanasakis ◽

M. Kakouros ◽

A. Skroumpelos ◽

J. Kyriopoulos

Keyword(s):

Lung Cancer ◽

Cost Effectiveness ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Treatment Options ◽

Locally Advanced ◽

Small Cell ◽

Small Cell Lung ◽

Prior Chemotherapy ◽

Effectiveness Analysis

Download Full-text

3 A phase II trial of chemoradiotherapy for locally advanced non-small cell lung cancer using a paclitaxel (TAXOL) based non-platinum containing chemotherapy regimen

Lung Cancer ◽

10.1016/s0169-5002(05)81474-6 ◽

2005 ◽

Vol 49 ◽

pp. S379

Author(s):

F. Abell ◽

R. Lynch ◽

R. Bell ◽

I. Howitt ◽

A. Woollett

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Chemotherapy Regimen ◽

Locally Advanced ◽

Small Cell ◽

Small Cell Lung

Download Full-text

Prospective, Noninterventional Study of Nivolumab in Real-world Patients With Locally Advanced or Metastatic Non–small Cell Lung Cancer After Prior Chemotherapy (ENLARGE-Lung)

Journal of Immunotherapy ◽

10.1097/cji.0000000000000397 ◽

2021 ◽

Vol Publish Ahead of Print ◽

Author(s):

Martin Sebastian ◽

Andreas Gröschel ◽

Sylvia Gütz ◽

Holger Schulz ◽

Harald Müller-Huesmann ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Real World ◽

Locally Advanced ◽

Small Cell ◽

Small Cell Lung ◽

Prior Chemotherapy ◽

Noninterventional Study

Download Full-text

Cost-Effectiveness Analysis of Atezolizumab Compared To The Standard of Care For The Treatment of Adult Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) After Prior Chemotherapy in Greece

Value in Health ◽

10.1016/j.jval.2017.08.233 ◽

2017 ◽

Vol 20 (9) ◽

pp. A439 ◽

Cited By ~ 1

Author(s):

N Kourkoulas ◽

D Kyriopoulos ◽

K Athanasakis

Keyword(s):

Lung Cancer ◽

Cost Effectiveness ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Locally Advanced ◽

Standard Of Care ◽

Small Cell ◽

Small Cell Lung ◽

Prior Chemotherapy ◽

Effectiveness Analysis

Download Full-text

A phase II study of erlotinib and bevacizumab in patients with locally advanced and/or metastatic (stage IIIB or IV) non-small cell lung cancer who have not received prior chemotherapy

http://isrctn.org/> ◽

10.1186/isrctn78329606 ◽

2013 ◽

Author(s):

H J M Groen

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Locally Advanced ◽

Small Cell ◽

Stage Iiib ◽

Small Cell Lung ◽

Prior Chemotherapy

Download Full-text

ENLARGE-Lung: Two-Year Follow-up of Real-World Patients with Locally Advanced or Metastatic (Stage IIIB/IV) Squamous and Non-Squamous Non-Small Cell Lung Cancer (NSCLC) from a National, Prospective, Non-Interventional Study (NIS ENLARGE) of Nivolumab after Prior Chemotherapy in Germany

10.1055/s-0039-3403146 ◽

2020 ◽

Author(s):

S Gütz ◽

C Schumann ◽

M Gröschel ◽

C Schulte ◽

H Schulz ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Real World ◽

Locally Advanced ◽

Small Cell ◽

Small Cell Lung ◽

Interventional Study ◽

Prior Chemotherapy

Download Full-text

ENLARGE Lung: First Interim Primary Cohort Data (n = 660) from a National, Prospective, Non-Interventional Study (NIS) of Nivolumab (Nivo) after Prior Chemotherapy in Patients (pts) with Locally Advanced or Metastatic (Stage IIIB/IV) Squamous/Non-squamous Non-Small Cell Lung Cancer (NSCLC)

10.1055/s-0039-1678137 ◽

2019 ◽

Author(s):

M Sebastian ◽

M Gröschel ◽

S Gütz ◽

H Schulz ◽

K Kratz-Albers ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Locally Advanced ◽

Small Cell ◽

Stage Iiib ◽

Small Cell Lung ◽

Interventional Study ◽

Prior Chemotherapy ◽

Cohort Data

Download Full-text